Publications found:
58,333
Sort by:
Renal Anemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF RENAL ANEMIA PIPELINE REPORT INCLUDES Panorama of Renal Anemia pipeline markets including statistics on therapeutic drugs and companies involved Renal Anemia Pipeline candidates across various development ...
August 2018
90 pages
Resistant Hypertension R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF RESISTANT HYPERTENSION PIPELINE REPORT INCLUDES Panorama of Resistant Hypertension pipeline markets including statistics on therapeutic drugs and companies involved Resistant Hypertension Pipeline candidates across various development ...
August 2018
30 pages
Resistant Pseudomonas aeruginosa Infection R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF RESISTANT PSEUDOMONAS AERUGINOSA INFECTION PIPELINE REPORT INCLUDES Panorama of Resistant Pseudomonas aeruginosa Infection pipeline markets including statistics on therapeutic drugs and companies involved Resistant Pseudomonas aeruginosa Infection Pipeline candidates across ...
August 2018
40 pages
Restenosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF RESTENOSIS PIPELINE REPORT INCLUDES Panorama of Restenosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Restless Legs Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF RESTLESS LEGS SYNDROME PIPELINE REPORT INCLUDES Panorama of Restless Legs Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Restless Legs Syndrome Pipeline candidates across various development ...
August 2018
40 pages
Retinal Vein Occlusion R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF RETINAL VEIN OCCLUSION PIPELINE REPORT INCLUDES Panorama of Retinal Vein Occlusion pipeline markets including statistics on therapeutic drugs and companies involved Retinal Vein Occlusion Pipeline candidates across various development ...
August 2018
80 pages
Retinitis Pigmentosa R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF RETINITIS PIGMENTOSA PIPELINE REPORT INCLUDES Panorama of Retinitis Pigmentosa pipeline markets including statistics on therapeutic drugs and companies involved Retinitis Pigmentosa Pipeline candidates across various development ...
August 2018
150 pages
Retinoblastoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF RETINOBLASTOMA PIPELINE REPORT INCLUDES Panorama of Retinoblastoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Retinopathy Of Prematurity (RoP) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF RETINOPATHY OF PREMATURITY (ROP) PIPELINE REPORT INCLUDES Panorama of Retinopathy Of Prematurity (RoP) pipeline markets including statistics on therapeutic drugs and companies involved Retinopathy Of Prematurity (RoP) Pipeline candidates across ...
August 2018
30 pages
Rett Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF RETT SYNDROME PIPELINE REPORT INCLUDES Panorama of Rett Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Rett Syndrome Pipeline candidates across various development ...
August 2018
90 pages
Rhabdomyosarcoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF RHABDOMYOSARCOMA PIPELINE REPORT INCLUDES Panorama of Rhabdomyosarcoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
210 pages
Rhino Conjunctivitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF RHINO CONJUNCTIVITIS PIPELINE REPORT INCLUDES Panorama of Rhino Conjunctivitis pipeline markets including statistics on therapeutic drugs and companies involved Rhino Conjunctivitis Pipeline candidates across various development ...
August 2018
60 pages
Rhinovirus Infections R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF RHINOVIRUS INFECTIONS PIPELINE REPORT INCLUDES Panorama of Rhinovirus Infections pipeline markets including statistics on therapeutic drugs and companies involved Rhinovirus Infections Pipeline candidates across various development ...
August 2018
30 pages
Rosacea R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF ROSACEA PIPELINE REPORT INCLUDES Panorama of Rosacea pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Rotavirus Infections R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF ROTAVIRUS INFECTIONS PIPELINE REPORT INCLUDES Panorama of Rotavirus Infections pipeline markets including statistics on therapeutic drugs and companies involved Rotavirus Infections Pipeline candidates across various development ...
August 2018
40 pages
Rubella (German Measles) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF RUBELLA (GERMAN MEASLES) PIPELINE REPORT INCLUDES Panorama of Rubella (German Measles) pipeline markets including statistics on therapeutic drugs and companies involved Rubella (German Measles) Pipeline candidates across various development ...
August 2018
30 pages
Salivary Gland Cancer R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF SALIVARY GLAND CANCER PIPELINE REPORT INCLUDES Panorama of Salivary Gland Cancer pipeline markets including statistics on therapeutic drugs and companies involved Salivary Gland Cancer Pipeline candidates across various development ...
August 2018
80 pages
Sandhoff Disease R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... with comprehensive information of Sandhoff Disease pipeline products. The Sandhoff Disease pipeline guide presents complete overview ... SANDHOFF DISEASE PIPELINE REPORT INCLUDES Panorama of Sandhoff Disease pipeline markets including statistics on therapeutic drugs and companies involved Sandhoff Disease Pipeline ...
August 2018
20 pages
Sarcopenia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF SARCOPENIA PIPELINE REPORT INCLUDES Panorama of Sarcopenia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Schistosomiasis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF SCHISTOSOMIASIS PIPELINE REPORT INCLUDES Panorama of Schistosomiasis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Seborrhea R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF SEBORRHEA PIPELINE REPORT INCLUDES Panorama of Seborrhea pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Secondary Hyperparathyroidism R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF SECONDARY HYPERPARATHYROIDISM PIPELINE REPORT INCLUDES Panorama of Secondary Hyperparathyroidism pipeline markets including statistics on therapeutic drugs and companies involved Secondary Hyperparathyroidism Pipeline candidates across various development ...
August 2018
30 pages
Secondary Progressive Multiple Sclerosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS PIPELINE REPORT INCLUDES Panorama of Secondary Progressive Multiple Sclerosis pipeline markets including statistics on therapeutic drugs and companies involved Secondary Progressive Multiple Sclerosis Pipeline candidates across ...
August 2018
100 pages
Sedation R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF SEDATION PIPELINE REPORT INCLUDES Panorama of Sedation pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Seizures R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF SEIZURES PIPELINE REPORT INCLUDES Panorama of Seizures pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
170 pages
Septic Shock R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF SEPTIC SHOCK PIPELINE REPORT INCLUDES Panorama of Septic Shock pipeline markets including statistics on therapeutic drugs and companies involved Septic Shock Pipeline candidates across various development ...
August 2018
70 pages
Severe Acute Respiratory Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF SEVERE ACUTE RESPIRATORY SYNDROME PIPELINE REPORT INCLUDES Panorama of Severe Acute Respiratory Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Severe Acute Respiratory Syndrome Pipeline candidates across ...
August 2018
40 pages
Short Bowel Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF SHORT BOWEL SYNDROME PIPELINE REPORT INCLUDES Panorama of Short Bowel Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Short Bowel Syndrome Pipeline candidates across various development ...
August 2018
40 pages
Sicca Syndrome (Sjogren) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF SICCA SYNDROME (SJOGREN) PIPELINE REPORT INCLUDES Panorama of Sicca Syndrome (Sjogren) pipeline markets including statistics on therapeutic drugs and companies involved Sicca Syndrome (Sjogren) Pipeline candidates across various development ...
August 2018
90 pages
Sickle Cell Disease R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF SICKLE CELL DISEASE PIPELINE REPORT INCLUDES Panorama of Sickle Cell Disease pipeline markets including statistics on therapeutic drugs and companies involved Sickle Cell Disease Pipeline candidates across various development ...
August 2018
150 pages
Sinusitis (Sinus Infection) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF SINUSITIS (SINUS INFECTION) PIPELINE REPORT INCLUDES Panorama of Sinusitis (Sinus Infection) pipeline markets including statistics on therapeutic drugs and companies involved Sinusitis (Sinus Infection) Pipeline candidates across various development ...
August 2018
70 pages
Skin And Soft Tissue Infections R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... . SCOPE OF SKIN AND SOFT TISSUE INFECTIONS PIPELINE REPORT INCLUDES Panorama of Skin And Soft Tissue Infections pipeline markets including statistics on therapeutic drugs and companies involved Skin And Soft Tissue Infections Pipeline ...
August 2018
30 pages
Sleep Apnea R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF SLEEP APNEA PIPELINE REPORT INCLUDES Panorama of Sleep Apnea pipeline markets including statistics on therapeutic drugs and companies involved Sleep Apnea Pipeline candidates across various development ...
August 2018
50 pages
Smallpox R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF SMALLPOX PIPELINE REPORT INCLUDES Panorama of Smallpox pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Smoking Addiction R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF SMOKING ADDICTION PIPELINE REPORT INCLUDES Panorama of Smoking Addiction pipeline markets including statistics on therapeutic drugs and companies involved Smoking Addiction Pipeline candidates across various development ...
August 2018
70 pages
Spinal Cord Injury R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF SPINAL CORD INJURY PIPELINE REPORT INCLUDES Panorama of Spinal Cord Injury pipeline markets including statistics on therapeutic drugs and companies involved Spinal Cord Injury Pipeline candidates across various development ...
August 2018
160 pages
Spinal Muscular Atrophy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF SPINAL MUSCULAR ATROPHY PIPELINE REPORT INCLUDES Panorama of Spinal Muscular Atrophy pipeline markets including statistics on therapeutic drugs and companies involved Spinal Muscular Atrophy Pipeline candidates across various development ...
August 2018
90 pages
Spinocerebellar Ataxia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF SPINOCEREBELLAR ATAXIA PIPELINE REPORT INCLUDES Panorama of Spinocerebellar Ataxia pipeline markets including statistics on therapeutic drugs and companies involved Spinocerebellar Ataxia Pipeline candidates across various development ...
August 2018
50 pages
Status Epilepticus R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF STATUS EPILEPTICUS PIPELINE REPORT INCLUDES Panorama of Status Epilepticus pipeline markets including statistics on therapeutic drugs and companies involved Status Epilepticus Pipeline candidates across various development ...
August 2018
50 pages
Streptococcal Pneumonia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF STREPTOCOCCAL PNEUMONIA PIPELINE REPORT INCLUDES Panorama of Streptococcal Pneumonia pipeline markets including statistics on therapeutic drugs and companies involved Streptococcal Pneumonia Pipeline candidates across various development ...
August 2018
130 pages
Streptococcus pyogenes Infection R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF STREPTOCOCCUS PYOGENES INFECTION PIPELINE REPORT INCLUDES Panorama of Streptococcus pyogenes Infection pipeline markets including statistics on therapeutic drugs and companies involved Streptococcus pyogenes Infection Pipeline candidates across various development ...
August 2018
30 pages
Synovial Sarcoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF SYNOVIAL SARCOMA PIPELINE REPORT INCLUDES Panorama of Synovial Sarcoma pipeline markets including statistics on therapeutic drugs and companies involved Synovial Sarcoma Pipeline candidates across various development ...
August 2018
170 pages
Systemic Idiopathic Juvenile Arthritis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF SYSTEMIC IDIOPATHIC JUVENILE ARTHRITIS PIPELINE REPORT INCLUDES Panorama of Systemic Idiopathic Juvenile Arthritis pipeline markets including statistics on therapeutic drugs and companies involved Systemic Idiopathic Juvenile Arthritis Pipeline candidates across ...
August 2018
40 pages
Systemic Mastocytosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF SYSTEMIC MASTOCYTOSIS PIPELINE REPORT INCLUDES Panorama of Systemic Mastocytosis pipeline markets including statistics on therapeutic drugs and companies involved Systemic Mastocytosis Pipeline candidates across various development ...
August 2018
110 pages
Systemic Sclerosis (Scleroderma) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF SYSTEMIC SCLEROSIS (SCLERODERMA) PIPELINE REPORT INCLUDES Panorama of Systemic Sclerosis (Scleroderma) pipeline markets including statistics on therapeutic drugs and companies involved Systemic Sclerosis (Scleroderma) Pipeline candidates across various development ...
August 2018
220 pages
Tetanus R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF TETANUS PIPELINE REPORT INCLUDES Panorama of Tetanus pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Thalassemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF THALASSEMIA PIPELINE REPORT INCLUDES Panorama of Thalassemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
120 pages
Thrombocytopenia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF THROMBOCYTOPENIA PIPELINE REPORT INCLUDES Panorama of Thrombocytopenia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
130 pages
Thromboembolism R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF THROMBOEMBOLISM PIPELINE REPORT INCLUDES Panorama of Thromboembolism pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Thrombotic Thrombocytopenic Purpura R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF THROMBOTIC THROMBOCYTOPENIC PURPURA PIPELINE REPORT INCLUDES Panorama of Thrombotic Thrombocytopenic Purpura pipeline markets including statistics on therapeutic drugs and companies involved Thrombotic Thrombocytopenic Purpura Pipeline candidates across various development ...
August 2018
50 pages
